According to this latest study, the 2021 growth of Hemoperfusion will have significant change from previous year. By the most conservative estimates of global Hemoperfusion market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 399.6 million in 2020. Over the next five years the Hemoperfusion market will register a 18.8% CAGR in terms of revenue, the global market size will reach US$ 795.4 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemoperfusion market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Activated Carbon Adsorption
Resin Adsorption
Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hepatic Encephalopathy
Certain Autoimmune Diseases
Drug Overdose
Specific Intoxications
Others
Hepatic Encephalopathy occupies the largest market share of Hepatic Encephalopathy and is the fastest growing
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Jafron Biomedical
Baxter (Gambro)
Asahi-Kasei
Biosun Medical
Kaneka
Toray Medical
Cytosorbents
Aier
Zibo Kangbei
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hemoperfusion Consumption 2016-2026
2.1.2 Hemoperfusion Consumption CAGR by Region
2.2 Hemoperfusion Segment by Type
2.2.1 Activated Carbon Adsorption
2.2.2 Resin Adsorption
2.3 Hemoperfusion Sales by Type
2.3.1 Global Hemoperfusion Sales Market Share by Type (2016-2021)
2.3.2 Global Hemoperfusion Revenue and Market Share by Type (2016-2021)
2.3.3 Global Hemoperfusion Sale Price by Type (2016-2021)
2.4 Hemoperfusion Segment by Application
2.4.1 Hepatic Encephalopathy
2.4.2 Certain Autoimmune Diseases
2.4.3 Drug Overdose
2.4.4 Specific Intoxications
2.4.5 Others
2.5 Hemoperfusion Sales by Application
2.5.1 Global Hemoperfusion Sale Market Share by Application (2016-2021)
2.5.2 Global Hemoperfusion Revenue and Market Share by Application (2016-2021)
2.5.3 Global Hemoperfusion Sale Price by Application (2016-2021)
3 Global Hemoperfusion by Company
3.1 Global Hemoperfusion Sales Market Share by Company
3.1.1 Global Hemoperfusion Sales by Company (2019-2021)
3.1.2 Global Hemoperfusion Sales Market Share by Company (2019-2021)
3.2 Global Hemoperfusion Revenue Market Share by Company
3.2.1 Global Hemoperfusion Revenue by Company (2019-2021)
3.2.2 Global Hemoperfusion Revenue Market Share by Company (2019-2021)
3.3 Global Hemoperfusion Sale Price by Company
3.4 Global Manufacturers Hemoperfusion Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemoperfusion Product Location Distribution
3.4.2 Players Hemoperfusion Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Hemoperfusion by Region
4.1 Global Hemoperfusion by Region
4.1.1 Global Hemoperfusion Sales by Region
4.1.2 Global Hemoperfusion Revenue by Region
4.2 Americas Hemoperfusion Sales Growth
4.3 APAC Hemoperfusion Sales Growth
4.4 Europe Hemoperfusion Sales Growth
4.5 Middle East & Africa Hemoperfusion Sales Growth
5 Americas
5.1 Americas Hemoperfusion Sales by Country
5.1.1 Americas Hemoperfusion Sales by Country (2016-2021)
5.1.2 Americas Hemoperfusion Revenue by Country (2016-2021)
5.2 Americas Hemoperfusion Sales by Type
5.3 Americas Hemoperfusion Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemoperfusion Sales by Region
6.1.1 APAC Hemoperfusion Sales by Region (2016-2021)
6.1.2 APAC Hemoperfusion Revenue by Region (2016-2021)
6.2 APAC Hemoperfusion Sales by Type
6.3 APAC Hemoperfusion Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Hemoperfusion by Country
7.1.1 Europe Hemoperfusion Sales by Country (2016-2021)
7.1.2 Europe Hemoperfusion Revenue by Country (2016-2021)
7.2 Europe Hemoperfusion Sales by Type
7.3 Europe Hemoperfusion Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hemoperfusion by Country
8.1.1 Middle East & Africa Hemoperfusion Sales by Country (2016-2021)
8.1.2 Middle East & Africa Hemoperfusion Revenue by Country (2016-2021)
8.2 Middle East & Africa Hemoperfusion Sales by Type
8.3 Middle East & Africa Hemoperfusion Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Hemoperfusion Distributors
10.3 Hemoperfusion Customer
11 Global Hemoperfusion Market Forecast
11.1 Global Hemoperfusion Forecast by Region
11.1.1 Global Hemoperfusion Forecast by Regions (2021-2026)
11.2.2 Global Hemoperfusion Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Hemoperfusion Forecast by Type
11.7 Global Hemoperfusion Forecast by Application
12 Key Players Analysis
12.1 Jafron Biomedical
12.1.1 Jafron Biomedical Company Information
12.1.2 Jafron Biomedical Hemoperfusion Product Offered
12.1.3 Jafron Biomedical Hemoperfusion Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Jafron Biomedical Main Business Overview
12.1.5 Jafron Biomedical Latest Developments
12.2 Baxter (Gambro)
12.2.1 Baxter (Gambro) Company Information
12.2.2 Baxter (Gambro) Hemoperfusion Product Offered
12.2.3 Baxter (Gambro) Hemoperfusion Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Baxter (Gambro) Main Business Overview
12.2.5 Baxter (Gambro) Latest Developments
12.3 Asahi-Kasei
12.3.1 Asahi-Kasei Company Information
12.3.2 Asahi-Kasei Hemoperfusion Product Offered
12.3.3 Asahi-Kasei Hemoperfusion Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Asahi-Kasei Main Business Overview
12.3.5 Asahi-Kasei Latest Developments
12.4 Biosun Medical
12.4.1 Biosun Medical Company Information
12.4.2 Biosun Medical Hemoperfusion Product Offered
12.4.3 Biosun Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Biosun Medical Main Business Overview
12.4.5 Biosun Medical Latest Developments
12.5 Kaneka
12.5.1 Kaneka Company Information
12.5.2 Kaneka Hemoperfusion Product Offered
12.5.3 Kaneka Hemoperfusion Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Kaneka Main Business Overview
12.5.5 Kaneka Latest Developments
12.6 Toray Medical
12.6.1 Toray Medical Company Information
12.6.2 Toray Medical Hemoperfusion Product Offered
12.6.3 Toray Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Toray Medical Main Business Overview
12.6.5 Toray Medical Latest Developments
12.7 Cytosorbents
12.7.1 Cytosorbents Company Information
12.7.2 Cytosorbents Hemoperfusion Product Offered
12.7.3 Cytosorbents Hemoperfusion Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Cytosorbents Main Business Overview
12.7.5 Cytosorbents Latest Developments
12.8 Aier
12.8.1 Aier Company Information
12.8.2 Aier Hemoperfusion Product Offered
12.8.3 Aier Hemoperfusion Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Aier Main Business Overview
12.8.5 Aier Latest Developments
12.9 Zibo Kangbei
12.9.1 Zibo Kangbei Company Information
12.9.2 Zibo Kangbei Hemoperfusion Product Offered
12.9.3 Zibo Kangbei Hemoperfusion Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Zibo Kangbei Main Business Overview
12.9.5 Zibo Kangbei Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Hemoperfusion Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Activated Carbon Adsorption
Table 3. Major Players of Resin Adsorption
Table 4. Global Hemoperfusion Sales by Type (2016-2021) & (K Units)
Table 5. Global Hemoperfusion Sales Market Share by Type (2016-2021)
Table 6. Global Hemoperfusion Revenue by Type (2016-2021) & ($ million)
Table 7. Global Hemoperfusion Revenue Market Share by Type (2016-2021)
Table 8. Global Hemoperfusion Sale Price by Type (2016-2021)
Table 9. Global Hemoperfusion Sales by Application (2016-2021) & (K Units)
Table 10. Global Hemoperfusion Sales Market Share by Application (2016-2021)
Table 11. Global Hemoperfusion Value by Application (2016-2021)
Table 12. Global Hemoperfusion Revenue Market Share by Application (2016-2021)
Table 13. Global Hemoperfusion Sale Price by Application (2016-2021)
Table 14. Global Hemoperfusion Sales by Company (2019-2021) & (K Units)
Table 15. Global Hemoperfusion Sales Market Share by Company (2019-2021)
Table 16. Global Hemoperfusion Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Hemoperfusion Revenue Market Share by Company (2019-2021)
Table 18. Global Hemoperfusion Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Hemoperfusion Producing Area Distribution and Sales Area
Table 20. Players Hemoperfusion Products Offered
Table 21. Hemoperfusion Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Hemoperfusion Sales by Region (2016-2021) (K Units)
Table 25. Global Hemoperfusion Sales Market Share by Region (2016-2021)
Table 26. Global Hemoperfusion Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Hemoperfusion Revenue Market Share by Region (2016-2021)
Table 28. Americas Hemoperfusion Sales by Country (2016-2021) & (K Units)
Table 29. Americas Hemoperfusion Sales Market Share by Country (2016-2021)
Table 30. Americas Hemoperfusion Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Hemoperfusion Revenue Market Share by Country (2016-2021)
Table 32. Americas Hemoperfusion Sales by Type (2016-2021) & (K Units)
Table 33. Americas Hemoperfusion Sales Market Share by Type (2016-2021)
Table 34. Americas Hemoperfusion Sales by Application (2016-2021) & (K Units)
Table 35. Americas Hemoperfusion Sales Market Share by Application (2016-2021)
Table 36. APAC Hemoperfusion Sales by Region (2016-2021) & (K Units)
Table 37. APAC Hemoperfusion Sales Market Share by Region (2016-2021)
Table 38. APAC Hemoperfusion Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Hemoperfusion Revenue Market Share by Region (2016-2021)
Table 40. APAC Hemoperfusion Sales by Type (2016-2021) & (K Units)
Table 41. APAC Hemoperfusion Sales Market Share by Type (2016-2021)
Table 42. APAC Hemoperfusion Sales by Application (2016-2021) & (K Units)
Table 43. APAC Hemoperfusion Sales Market Share by Application (2016-2021)
Table 44. Europe Hemoperfusion Sales by Country (2016-2021) & (K Units)
Table 45. Europe Hemoperfusion Sales Market Share by Country (2016-2021)
Table 46. Europe Hemoperfusion Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Hemoperfusion Revenue Market Share by Country (2016-2021)
Table 48. Europe Hemoperfusion Sales by Type (2016-2021) & (K Units)
Table 49. Europe Hemoperfusion Sales Market Share by Type (2016-2021)
Table 50. Europe Hemoperfusion Sales by Application (2016-2021) & (K Units)
Table 51. Europe Hemoperfusion Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Hemoperfusion Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Hemoperfusion Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Hemoperfusion Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Hemoperfusion Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Hemoperfusion Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Hemoperfusion Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Hemoperfusion Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Hemoperfusion Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Hemoperfusion
Table 61. Key Application and Potential Industries of Hemoperfusion
Table 62. Key Challenges of Hemoperfusion
Table 63. Key Trends of Hemoperfusion
Table 64. Hemoperfusion Distributors List
Table 65. Hemoperfusion Customer List
Table 66. Global Hemoperfusion Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Hemoperfusion Consumption Market Forecast by Region
Table 68. Global Hemoperfusion Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Hemoperfusion Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Hemoperfusion Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Hemoperfusion Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Hemoperfusion Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Hemoperfusion Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Hemoperfusion Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Hemoperfusion Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Hemoperfusion Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Hemoperfusion Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Hemoperfusion Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Hemoperfusion Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Hemoperfusion Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Hemoperfusion Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Hemoperfusion Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Hemoperfusion Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Hemoperfusion Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Hemoperfusion Revenue Market Share Forecast by Application (2021-2026)
Table 86. Jafron Biomedical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 87. Jafron Biomedical Hemoperfusion Product Offered
Table 88. Jafron Biomedical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 89. Jafron Biomedical Main Business
Table 90. Jafron Biomedical Latest Developments
Table 91. Baxter (Gambro) Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 92. Baxter (Gambro) Hemoperfusion Product Offered
Table 93. Baxter (Gambro) Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 94. Baxter (Gambro) Main Business
Table 95. Baxter (Gambro) Latest Developments
Table 96. Asahi-Kasei Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 97. Asahi-Kasei Hemoperfusion Product Offered
Table 98. Asahi-Kasei Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 99. Asahi-Kasei Main Business
Table 100. Asahi-Kasei Latest Developments
Table 101. Biosun Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 102. Biosun Medical Hemoperfusion Product Offered
Table 103. Biosun Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 104. Biosun Medical Main Business
Table 105. Biosun Medical Latest Developments
Table 106. Kaneka Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 107. Kaneka Hemoperfusion Product Offered
Table 108. Kaneka Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 109. Kaneka Main Business
Table 110. Kaneka Latest Developments
Table 111. Toray Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 112. Toray Medical Hemoperfusion Product Offered
Table 113. Toray Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 114. Toray Medical Main Business
Table 115. Toray Medical Latest Developments
Table 116. Cytosorbents Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 117. Cytosorbents Hemoperfusion Product Offered
Table 118. Cytosorbents Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 119. Cytosorbents Main Business
Table 120. Cytosorbents Latest Developments
Table 121. Aier Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 122. Aier Hemoperfusion Product Offered
Table 123. Aier Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 124. Aier Main Business
Table 125. Aier Latest Developments
Table 126. Zibo Kangbei Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 127. Zibo Kangbei Hemoperfusion Product Offered
Table 128. Zibo Kangbei Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 129. Zibo Kangbei Main Business
Table 130. Zibo Kangbei Latest Developments
List of Figures
Figure 1. Picture of Hemoperfusion
Figure 2. Hemoperfusion Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemoperfusion Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Hemoperfusion Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Hemoperfusion Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Activated Carbon Adsorption
Figure 10. Product Picture of Resin Adsorption
Figure 11. Global Hemoperfusion Sales Market Share by Type in 2020
Figure 12. Global Hemoperfusion Revenue Market Share by Type (2016-2021)
Figure 13. Hemoperfusion Consumed in Hepatic Encephalopathy
Figure 14. Global Hemoperfusion Market: Hepatic Encephalopathy (2016-2021) & (K Units)
Figure 15. Hemoperfusion Consumed in Certain Autoimmune Diseases
Figure 16. Global Hemoperfusion Market: Certain Autoimmune Diseases (2016-2021) & (K Units)
Figure 17. Hemoperfusion Consumed in Drug Overdose
Figure 18. Global Hemoperfusion Market: Drug Overdose (2016-2021) & (K Units)
Figure 19. Hemoperfusion Consumed in Specific Intoxications
Figure 20. Global Hemoperfusion Market: Specific Intoxications (2016-2021) & (K Units)
Figure 21. Hemoperfusion Consumed in Others
Figure 22. Global Hemoperfusion Market: Others (2016-2021) & (K Units)
Figure 23. Global Hemoperfusion Sales Market Share by Application (2016-2021)
Figure 24. Global Hemoperfusion Revenue Market Share by Application in 2020
Figure 25. Hemoperfusion Revenue Market by Company in 2020 ($ Million)
Figure 26. Global Hemoperfusion Revenue Market Share by Company in 2020
Figure 27. Global Hemoperfusion Sales Market Share by Regions (2016-2021)
Figure 28. Global Hemoperfusion Revenue Market Share by Region in 2020
Figure 29. Americas Hemoperfusion Sales 2016-2021 (K Units)
Figure 30. Americas Hemoperfusion Revenue 2016-2021 ($ Millions)
Figure 31. APAC Hemoperfusion Sales 2016-2021 (K Units)
Figure 32. APAC Hemoperfusion Revenue 2016-2021 ($ Millions)
Figure 33. Europe Hemoperfusion Sales 2016-2021 (K Units)
Figure 34. Europe Hemoperfusion Revenue 2016-2021 ($ Millions)
Figure 35. Middle East & Africa Hemoperfusion Sales 2016-2021 (K Units)
Figure 36. Middle East & Africa Hemoperfusion Revenue 2016-2021 ($ Millions)
Figure 37. Americas Hemoperfusion Sales Market Share by Country in 2020
Figure 38. Americas Hemoperfusion Revenue Market Share by Country in 2020
Figure 39. Americas Hemoperfusion Sales Market Share by Type in 2020
Figure 40. Americas Hemoperfusion Sales Market Share by Application in 2020
Figure 41. United States Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 42. Canada Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 43. Mexico Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 44. Brazil Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 45. APAC Hemoperfusion Sales Market Share by Region in 2020
Figure 46. APAC Hemoperfusion Revenue Market Share by Regions in 2020
Figure 47. APAC Hemoperfusion Sales Market Share by Type in 2020
Figure 48. APAC Hemoperfusion Sales Market Share by Application in 2020
Figure 49. China Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 50. Japan Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 51. Korea Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 52. Southeast Asia Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 53. India Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 54. Australia Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 55. Europe Hemoperfusion Sales Market Share by Country in 2020
Figure 56. Europe Hemoperfusion Revenue Market Share by Country in 2020
Figure 57. Europe Hemoperfusion Sales Market Share by Type in 2020
Figure 58. Europe Hemoperfusion Sales Market Share by Application in 2020
Figure 59. Germany Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 60. France Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 61. UK Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 62. Italy Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 63. Russia Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 64. Middle East & Africa Hemoperfusion Sales Market Share by Country in 2020
Figure 65. Middle East & Africa Hemoperfusion Revenue Market Share by Country in 2020
Figure 66. Middle East & Africa Hemoperfusion Sales Market Share by Type in 2020
Figure 67. Middle East & Africa Hemoperfusion Sales Market Share by Application in 2020
Figure 68. Egypt Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 69. South Africa Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 70. Israel Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 71. Turkey Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 72. GCC Country Hemoperfusion Revenue Growth 2016-2021 ($ Millions)
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles